Literature DB >> 6253823

Mutants of avian myelocytomatosis virus with smaller gag gene-related proteins have an altered transforming ability.

G Ramsay, T Graf, M J Hayman.   

Abstract

Avian myelocytomatosis virus strain MC29 is a replication-defective avian oncovirus which in newborn chickens causes myelocytomatosis and liver and kidney tumours. In vitro infection of bone marrow cells gives rise to colonies of transformed macrophage-like cells, and cloned viruses is also capable of transforming fibroblasts. The genome of MC29 contains cellular sequences which are closely related to those in other defective leukaemia viruses with similar transforming spectra. Consequently, these cellular sequences have been postulated to represent a new oncogene which has been designated mac, for macrophage transformation. MC29-transformed cells contain a gag gene-related protein of a 110,000 molecular weight (MW) (p110), which by tryptic peptide analysis has been shown to be a fusion product comprised of a gag gene-derived sequences and sequences which are presumed to be coded by the adjacent mac gene. These findings suggest that this protein may be implicated in transformation by MC29. We now describe three mutants of MC29 and synthesize smaller gag gene-related proteins. These mutants have an altered ability to transform bone marrow cells but not fibroblasts. This demonstrates for the first time a direct involvement of the p110 protein of MC29 in transformation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253823     DOI: 10.1038/288170a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity distinct from v-myc that may be modulated by adjacent normal cell neighbors.

Authors:  E J Filardo; E H Humphries
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 3.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

4.  Distinctive effects of the viral oncogenes myc, erb, fps, and src on the differentiation program of quail myogenic cells.

Authors:  G Falcone; F Tatò; S Alemà
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts.

Authors:  S Alema; F Tato; D Boettiger
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

6.  Nucleotide sequence of HBI, a novel recombinant MC29 derivative with altered pathogenic properties.

Authors:  D R Smith; B Vennstrom; M J Hayman; P J Enrietto
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Isolation of an MH2 retrovirus mutant temperature sensitive for macrophage but not fibroblast transformation.

Authors:  S Palmieri
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

8.  Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins.

Authors:  M L Heaney; J Pierce; J T Parsons
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

9.  FH3, a v-myc avian retrovirus with limited transforming ability.

Authors:  C Chen; B J Biegalke; R N Eisenman; M L Linial
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Cellular myc (c-myc) in fish (rainbow trout): its relationship to other vertebrate myc genes and to the transforming genes of the MC29 family of viruses.

Authors:  R J Van Beneden; D K Watson; T T Chen; J A Lautenberger; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.